Novocure Ltd (NVCR)

Apr 25, 2025

NovoCure Ltd [NVCR] Shares Jump Approximately 56.80% Over the Year - knoxdaily.com

Apr 25, 2025

Apr 25, 2025

H.C. Wainwright maintains Buy on NovoCure, $38 price target - Investing.com

Apr 25, 2025

Apr 25, 2025

NovoCure Limited (NASDAQ:NVCR) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 25, 2025

Apr 25, 2025

NovoCure (NASDAQ:NVCR) Cut to “Sell” at StockNews.com - Defense World

Apr 25, 2025

Apr 25, 2025

NovoCure: Q1 Earnings Snapshot - Huron Daily Tribune

Apr 25, 2025

Apr 25, 2025

Bank of Montreal Can Buys New Position in NovoCure Limited (NASDAQ:NVCR) - Defense World

Apr 25, 2025

Apr 25, 2025

Decoding NovoCure Ltd (NVCR): A Strategic SWOT Insight - GuruFocus

Apr 25, 2025

Apr 25, 2025

Novocure’s Q1 2025: Revenue Growth and Strategic Advances - TipRanks

Apr 25, 2025

Apr 24, 2025

NovoCure Ltd. Earnings Call: Growth Amid Financial Challenges - TipRanks

Apr 24, 2025

Apr 24, 2025

NovoCure (NVCR) Stock Rises on Strong Quarterly Earnings - GuruFocus

Apr 24, 2025

Apr 24, 2025

Novocure (NVCR) Sees Early Revenue from Lung Cancer Treatments | NVCR Stock News - GuruFocus

Apr 24, 2025

Apr 24, 2025

NovoCure Warns Of Potential $11 Million Tariff Hit If US Trade Pause Expires In 2025 - Benzinga

Apr 24, 2025

Apr 24, 2025

Novocure’s device for metastatic NSCLC treatment gains CE Mark - MSN

Apr 24, 2025

Apr 24, 2025

NovoCure (NVCR) Reports Strong Q1 Revenue Growth Amid Optune Lua Expansion - GuruFocus

Apr 24, 2025

Apr 24, 2025

Stocks of NovoCure Ltd (NVCR) are poised to climb above their peers - Sete News

Apr 24, 2025

Apr 24, 2025

NovoCure Surpasses Q1 Expectations - Mitrade

Apr 24, 2025

Apr 24, 2025

NovoCure (NVCR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Apr 24, 2025

Apr 24, 2025

NovoCure Surpasses Q1 Expectations - The Motley Fool

Apr 24, 2025

Apr 24, 2025

NovoCure Ltd Reports Q1 2025 Earnings: EPS Loss of $0.31 Beats E - GuruFocus

Apr 24, 2025

Apr 24, 2025

Novocure Ltd earnings beat by $0.18, revenue topped estimates - Investing.com India

Apr 24, 2025

Apr 24, 2025

Novocure (NVCR) Surpasses Q1 Revenue Projections, Reports $154.99M | NVCR Stock News - GuruFocus

Apr 24, 2025

Apr 24, 2025

NovoCure Ltd Reports Q1 2025 Earnings: EPS Loss of $0.31 Beats Estimate, Revenue of $155 Million Exceeds Expectations - GuruFocus

Apr 24, 2025

Apr 24, 2025

Novocure Reports First Quarter 2025 Financial Results | NVCR Stock News - GuruFocus

Apr 24, 2025

Apr 24, 2025

Novocure Reports First Quarter 2025 Financial Results - TradingView

Apr 24, 2025

Apr 24, 2025

NovoCure Ltd SEC 10-Q Report - TradingView

Apr 24, 2025

Apr 23, 2025

Novocure to present Phase 3 PANOVA-3 trial results at ASCO 2025 - TipRanks

Apr 23, 2025

Apr 23, 2025

NovoCure's Earnings: A Preview - Benzinga

Apr 23, 2025

Apr 23, 2025

Novocure (NVCR) to Showcase Key PANOVA-3 Trial Findings at ASCO 2025 | NVCR Stock News - GuruFocus

Apr 23, 2025

Apr 23, 2025

Novocure to Present Results from the Phase 3 PANOVA-3 Clinical T - GuruFocus

Apr 23, 2025

Apr 23, 2025

Novocure price target lowered to $34 from $42 at Piper Sandler - TipRanks

Apr 23, 2025

Apr 23, 2025

Novocure (NVCR) Faces Revised Price Target Amid Investor Opportunities | NVCR Stock News - GuruFocus

Apr 23, 2025

Apr 22, 2025

Novocure sees 6% spike from EU nod for electric lung cancer therapy gadget - Mugglehead Magazine

Apr 22, 2025

Apr 22, 2025

Novocure (NVCR) Gains CE Mark for Optune Lua in Lung Cancer Treatment | NVCR Stock News - GuruFocus

Apr 22, 2025

Apr 22, 2025

Novocure's Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer | NVCR Stock News - GuruFocus

Apr 22, 2025

Apr 22, 2025

Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer - Yahoo Finance

Apr 22, 2025

Apr 22, 2025

LPL Financial LLC Acquires Shares of 27,861 NovoCure Limited (NASDAQ:NVCR) - Defense World

Apr 22, 2025

Apr 19, 2025

Wedbush Issues Pessimistic Forecast for NovoCure Earnings - Defense World

Apr 19, 2025

Apr 18, 2025

NovoCure (NASDAQ:NVCR) vs. Sonoma Pharmaceuticals (NASDAQ:SNOA) Financial Review - Defense World

Apr 18, 2025

Apr 17, 2025

NovoCure (NVCR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

Apr 17, 2025

Apr 17, 2025

Why NovoCure Stock Was Withering on Wednesday - MSN

Apr 17, 2025

Apr 17, 2025

NovoCure (NASDAQ:NVCR) Upgraded to “Hold” at StockNews.com - Defense World

Apr 17, 2025

Apr 16, 2025

Why NovoCure (NVCR) Stock Fell Today - GuruFocus

Apr 16, 2025

Apr 16, 2025

Novocure price target lowered to $27 from $29 at Wedbush - TipRanks

Apr 16, 2025

Apr 16, 2025

Wedbush Adjusts Price Target for Novocure (NVCR) Ahead of Earnings Report | NVCR Stock News - GuruFocus

Apr 16, 2025

Apr 15, 2025

NovoCure Limited (NASDAQ:NVCR) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Apr 15, 2025

Apr 12, 2025

JPMorgan Chase & Co. Has Lowered Expectations for NovoCure (NASDAQ:NVCR) Stock Price - Defense World

Apr 12, 2025

Apr 10, 2025

11,672 Shares in NovoCure Limited (NASDAQ:NVCR) Bought by Raymond James Financial Inc. - Defense World

Apr 10, 2025

Apr 09, 2025

NovoCure Escapes Investor Suit Over Cancer Therapy Trial Data - Bloomberg Law News

Apr 09, 2025

Apr 09, 2025

NovoCure (NASDAQ:NVCR) Lowered to Sell Rating by StockNews.com - Defense World

Apr 09, 2025

Apr 08, 2025

NovoCure (NASDAQ:NVCR investor three-year losses grow to 80% as the stock sheds US$133m this past week - simplywall.st

Apr 08, 2025

Apr 03, 2025

Thrivent Financial for Lutherans Reduces Position in NovoCure Limited (NASDAQ:NVCR) - Defense World

Apr 03, 2025

Apr 03, 2025

Corebridge Financial Inc. Has $1.58 Million Holdings in NovoCure Limited (NASDAQ:NVCR) - Defense World

Apr 03, 2025

Apr 01, 2025

Novocure to Report First Quarter 2025 Financial Results - Yahoo Finance

Apr 01, 2025